TY - JOUR
T1 - Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (ra) in recent years
T2 - Dawn of a new era in cardiovascular disease in ra?
AU - Myasoedova, Elena
AU - Gabriel, Sherine E.
AU - Matteson, Eric L.
AU - Davis, John M.
AU - Therneau, Terry M.
AU - Crowson, Cynthia S.
N1 - Funding Information:
Funded by a grant from the US National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR46849). Research reported in this publication was supported by the US National Institute on Aging of the NIH under award number R01AG034676.
Publisher Copyright:
© Copyright 2017. All rights reserved.
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Objective. To assess trends in cardiovascular (CV) mortality in patients with incident rheumatoid arthritis (RA) in 2000-07 versus the previous decades, compared with non-RA subjects. Methods. The study population consisted of Olmsted County, Minnesota, USA residents with incident RA (age ? 18 yrs, 1987 American College of Rheumatology criteria was met in 1980-2007) and non-RA subjects from the same underlying population with similar age, sex, and calendar year of index. All subjects were followed until death, migration, or December 31, 2014. Followup was truncated for comparability. Aalen-Johansen methods were used to estimate CV mortality rates, adjusting for competing risk of other causes. Cox proportional hazards models were used to compare CV mortality by decade. Results. The study included 813 patients with RA and 813 non-RA subjects (mean age 55.9 yrs; 68% women for both groups). Patients with incident RA in 2000-07 had markedly lower 10-year overall CV mortality (2.7%, 95% CI 0.6-4.9%) and coronary heart disease (CHD) mortality (1.1%, 95% CI 0.0-2.7%) than patients diagnosed in 1990-99 (7.1%, 95% CI 3.9-10.1% and 4.5%, 95% CI 1.9-7.1%, respectively; HR for overall CV death: 0.43, 95% CI 0.19-0.94; CHD death: HR 0.21, 95% CI 0.05-0.95). This improvement in CV mortality persisted after accounting for CV risk factors. Ten-year overall CV mortality and CHD mortality in 2000-07 RA incidence cohort was similar to non-RA subjects (p = 0.95 and p = 0.79, respectively). Conclusion. Our findings suggest significantly improved overall CV mortality, particularly CHD mortality, in patients with RA in recent years. Further studies are needed to examine the reasons for this improvement.
AB - Objective. To assess trends in cardiovascular (CV) mortality in patients with incident rheumatoid arthritis (RA) in 2000-07 versus the previous decades, compared with non-RA subjects. Methods. The study population consisted of Olmsted County, Minnesota, USA residents with incident RA (age ? 18 yrs, 1987 American College of Rheumatology criteria was met in 1980-2007) and non-RA subjects from the same underlying population with similar age, sex, and calendar year of index. All subjects were followed until death, migration, or December 31, 2014. Followup was truncated for comparability. Aalen-Johansen methods were used to estimate CV mortality rates, adjusting for competing risk of other causes. Cox proportional hazards models were used to compare CV mortality by decade. Results. The study included 813 patients with RA and 813 non-RA subjects (mean age 55.9 yrs; 68% women for both groups). Patients with incident RA in 2000-07 had markedly lower 10-year overall CV mortality (2.7%, 95% CI 0.6-4.9%) and coronary heart disease (CHD) mortality (1.1%, 95% CI 0.0-2.7%) than patients diagnosed in 1990-99 (7.1%, 95% CI 3.9-10.1% and 4.5%, 95% CI 1.9-7.1%, respectively; HR for overall CV death: 0.43, 95% CI 0.19-0.94; CHD death: HR 0.21, 95% CI 0.05-0.95). This improvement in CV mortality persisted after accounting for CV risk factors. Ten-year overall CV mortality and CHD mortality in 2000-07 RA incidence cohort was similar to non-RA subjects (p = 0.95 and p = 0.79, respectively). Conclusion. Our findings suggest significantly improved overall CV mortality, particularly CHD mortality, in patients with RA in recent years. Further studies are needed to examine the reasons for this improvement.
KW - CARDiOVASCULAR DiSEASE
KW - CORONARY HEART DiSEASE
KW - MORTALITY
KW - RHEUMATOID ARTHRITIS
UR - http://www.scopus.com/inward/record.url?scp=85020206942&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020206942&partnerID=8YFLogxK
U2 - 10.3899/jrheum.161154
DO - 10.3899/jrheum.161154
M3 - Article
C2 - 28365576
AN - SCOPUS:85020206942
SN - 0315-162X
VL - 44
SP - 732
EP - 739
JO - Journal of Rheumatology
JF - Journal of Rheumatology
IS - 6
ER -